Shenzhen - January 9, 2026 - Shenzhen Cell Valley Biomedical Co., Ltd. has been honored on the 2025 Shenzhen "Specialized, Sophisticated, Distinctive, and Innovative" Small and Medium-sized Enterprises Recognition List, officially approved as one of Shenzhen's SSDI SMEs. This honor was published and publicized by the Shenzhen Small and Medium-sized Enterprises Service Bureau, marking that Shenzhen Cell Valley has received authoritative government recognition for its technological innovation, market specialization, and high-quality development capabilities.

As an important participant in the cell therapy industry, Shenzhen Cell Valley has continuously focused on the market promotion and application services of cell therapy products in recent years, particularly achieving outstanding performance in the fields of NK cell immunotherapy, mesenchymal stem cell products, and anti-aging cell therapy services. Through sustained investment in research and development, refined market operations, and high-standard quality control, the company has established a strong reputation within the industry and played an active role in promoting the standardized development of the sector.

Receiving the SSDI SME qualification not only reflects the government's high recognition of Shenzhen Cell Valley's technical capabilities and market performance but will also bring new opportunities for the company's future expansion in capital markets, policy support, and industrial ecosystem collaboration. Relevant Shenzhen departments have continuously increased their support for SSDI SMEs in recent years, including multi-dimensional assistance such as technological innovation support, fiscal incentive policies, and capital connection services, helping to enhance core competitiveness and value creation capabilities within the industrial chain.

Shenzhen Cell Valley will take this selection as a new starting point, continuing to deepen technological research and development and market innovation, accelerating the implementation of high-quality products and services, and contributing greater strength to promoting the development of Shenzhen's biomedical industry and enhancing the region's technological innovation capabilities.